LY 377770
Latest Information Update: 30 Jul 2002
At a glance
- Originator Eli Lilly and Company
- Class Neuroprotectants
- Mechanism of Action AMPA receptor antagonists; Kainic acid receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Neurological disorders